Immunodiagnostic Systems Hldgs PLC Director/PDMR Shareholding (2753F)

TIDMIDH

RNS Number : 2753F

Immunodiagnostic Systems Hldgs PLC

11 July 2019

Immunodiagnostic Systems Holdings PLC

Director/PDMR Dealing

11 July 2019

Immunodiagnostic Systems Holdings PLC ("IDS") a specialist producer of manual and automated diagnostic testing kits and instruments for the clinical and research markets, announces that it has granted the following options to persons discharging managerial responsibilities to acquire ordinary shares of 2p in the capital of the Company under the Company's Co-Investment Executive Option Scheme.

 
                 Position           Date of Grant   Number of Options   Exercise Price 
 Paul Martin     Finance Director   28 March 2017              30,000         GBP1.320 
                -----------------  --------------  ------------------  --------------- 
                                    28 March 2017               9,000         GBP2.775 
                -----------------  --------------  ------------------  --------------- 
                                    29 March 2018               6,000         GBP2.200 
                                   --------------  ------------------  --------------- 
                                    29 March 2018               6,300         GBP2.900 
                                   --------------  ------------------  --------------- 
                                    28 March 2019               6,750         GBP1.840 
                -----------------  --------------  ------------------  --------------- 
 Jaap Stuut      CEO                29 March 2018               7,500         GBP2.200 
                -----------------  --------------  ------------------  --------------- 
                                    28 March 2019               7,500         GBP1.900 
                -----------------  --------------  ------------------  --------------- 
 Nicola Mitton   HR Director        29 March 2018               3,000         GBP2.200 
                -----------------  --------------  ------------------  --------------- 
 

Under this scheme, participants who purchase ordinary shares in the Company ("Co-Investment Shares") are entitled to three share options for each Co-Investment Share they purchase. The exercise price for the options is set at the price the participant paid for each Co-Investment Share.

The options are subject to the satisfaction of performance conditions and vest after a period of 3 years. The Options are exercisable over the period of 10 years from the date of grant.

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

For further information:

 
 Immunodiagnostic Systems Holdings     Tel : +44 (0)191 
  plc                                   519 0660 
 Paul Martin, Group Finance Director 
 
 Peel Hunt LLP                         Tel : +44 (0)207 
                                        418 8900 
 James Steel 
 Oliver Jackson 
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1.   Details of the person discharging managerial responsibilities 
       / person closely associated 
 a.   Name                     1. Paul Martin 
                                2. Jaap Stuut 
                                3. Nicola Mitton 
     ------------------  ------------------------------------------------------- 
 2.   Reason for the notification 
     --------------------------------------------------------------------------- 
 a.   Position/                1. Group Finance Director 
       status                   2. Chief Executive Officer 
                                3. HR Director 
     ------------------  ------------------------------------------------------- 
 a.   Initial             Initial 
       notification 
       /Amendment 
     ------------------  ------------------------------------------------------- 
 3.   Details of the issuer, emission allowance market 
       participant, auction platform, auctioneer or auction 
       monitor 
     --------------------------------------------------------------------------- 
 a.   Name                Immunodiagnostic Systems Holdings plc 
     ------------------  ------------------------------------------------------- 
 b.   LEI                 213800HZMYTD4NGF4L78 
     ------------------  ------------------------------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     --------------------------------------------------------------------------- 
 a.   Description         Options over ordinary shares of 2p each 
       of the Financial    in Immunodiagnostic Systems Holdings plc 
       instrument, 
       Type of             Ordinary shares 
       instrument          GB00B01YZ052 
       Identification 
       code 
     ------------------  ------------------------------------------------------- 
 b.   Nature of           Grant of options 
       the transaction 
     ------------------  ------------------------------------------------------- 
 c.   Price(s)                           Date of Grant   Number        Exercise 
       and volume(s)                                       of Options    Price 
                            Paul Martin   28 March             30,000   GBP1.320 
                                           2017 
                                         --------------  ------------  --------- 
                                          28 March              9,000   GBP2.775 
                                           2017 
                                         --------------  ------------  --------- 
                                          29 March              6,000   GBP2.200 
                                           2018 
                                         --------------  ------------  --------- 
                                          29 March              6,300   GBP2.900 
                                           2018 
                                         --------------  ------------  --------- 
                                          28 March              6,750   GBP1.840 
                                           2019 
                                         --------------  ------------  --------- 
                            Jaap Stuut    29 March              7,500   GBP2.200 
                                           2018 
                                         --------------  ------------  --------- 
                                          28 March              7,500   GBP1.900 
                                           2019 
                                         --------------  ------------  --------- 
                            Nicola        29 March              3,000   GBP2.200 
                             Mitton        2018 
                                         --------------  ------------  --------- 
     ------------------  ------------------------------------------------------- 
 d.   Aggregated          N/A 
       information 
     ------------------  ------------------------------------------------------- 
 e.   Date of             see table above in section c 
       the transaction 
     ------------------  ------------------------------------------------------- 
 f.   Place of            Outside trading venue - shares to be admitted 
       the transaction     to AIM market of London Stock Exchange 
                           plc on exercise of options 
     ------------------  ------------------------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHBXGDRSBBBGCB

(END) Dow Jones Newswires

July 11, 2019 09:16 ET (13:16 GMT)